<DOC>
	<DOCNO>NCT00919477</DOCNO>
	<brief_summary>To gather information safety monotherapy Casodex® tablets 80 mg , target prostate cancer patient history receive treatment either endocrine therapy ( include surgical castration ) .</brief_summary>
	<brief_title>Protocol Specified Clinical Experience Investigation Single Use Casodex® Tablet 80 mg</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>Prostate cancer patient history receive endocrine therapy ( include surgical castration ) , plan undergo Casodex® tablet monotherapy less 12 month</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Casodex</keyword>
	<keyword>Monotherapy</keyword>
</DOC>